红日药业(300026.SZ)：注射用多黏菌素E甲磺酸钠获药物临床试验批件

智通财经03-20

智通财经APP讯，红日药业(300026.SZ)公告，公司近日收到国家药品监督管理局下发的药物临床试验批准通知书，公司申报的注射用多黏菌素E甲磺酸钠符合药品注册的有关要求，同意本品开展临床试验。申请的适应症为：本品适用于革兰氏阴性杆菌敏感菌株引起的急性或慢性感染。特别是由铜绿假单胞菌敏感菌株引起的感染。本品不适用于由变形杆菌或奈瑟菌引起的感染。本品对于由产气肠杆菌、大肠杆菌、肺炎克雷伯菌和铜绿假...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2620781361?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-20 17:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620781361","market":"fut","top_or_hot":-1,"title":"红日药业(300026.SZ)：注射用多黏菌素E甲磺酸钠获药物临床试验批件","media":"智通财经","content":"<div>\n<p>智通财经APP讯，红日药业(300026.SZ)公告，公司近日收到国家药品监督管理局下发的药物临床试验批准通知书，公司申报的注射用多黏菌素E甲磺酸钠符合药品注册的有关要求，同意本品开展临床试验。申请的适应症为：本品适用于革兰氏阴性杆菌敏感菌株引起的急性或慢性感染。特别是由铜绿假单胞菌敏感菌株引起的感染。本品不适用于由变形杆菌或奈瑟菌引起的感染。本品对于由产气肠杆菌、大肠杆菌、肺炎克雷伯菌和铜绿假...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1416602.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>红日药业(300026.SZ)：注射用多黏菌素E甲磺酸钠获药物临床试验批件</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n红日药业(300026.SZ)：注射用多黏菌素E甲磺酸钠获药物临床试验批件\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-20 17:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1416602.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，红日药业(300026.SZ)公告，公司近日收到国家药品监督管理局下发的药物临床试验批准通知书，公司申报的注射用多黏菌素E甲磺酸钠符合药品注册的有关要求，同意本品开展临床试验。申请的适应症为：本品适用于革兰氏阴性杆菌敏感菌株引起的急性或慢性感染。特别是由铜绿假单胞菌敏感菌株引起的感染。本品不适用于由变形杆菌或奈瑟菌引起的感染。本品对于由产气肠杆菌、大肠杆菌、肺炎克雷伯菌和铜绿假...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1416602.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0077","symbol_name":"质押式回购","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1416602.html","article_id":"2620781361","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620781361","pubTimestamp":1773997779,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，红日药业(300026.SZ)公告，公司近日收到国家药品监督管理局下发的药物临床试验批准通知书，公司申报的注射用多黏菌素E甲磺酸钠符合药品注册的有关要求，同意本品开展临床试验。申请的适应症为：本品适用于革兰氏阴性杆菌敏感菌株引起的急性或慢性感染。特别是由铜绿假单胞菌敏感菌株引起的感染。本品不适用于由变形杆菌或奈瑟菌引起的感染。本品对于由产气肠杆菌、大肠杆菌、肺炎克雷伯菌和铜绿假单胞菌引起的感染的临床有效性已经获得证实。本品可用于治疗疑似由革兰氏阴性菌引起的严重感染和敏感革兰氏阴性杆菌引起的感染。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300026":"红日药业","BK0077":"质押式回购","BK0239":"医药制造","BK0188":"融资融券"},"translate_title":"Hongri Pharmaceutical (300026.SZ): Polymyxin E sodium mesylate for injection obtained drug clinical trial approval","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300026":1.5},"content_text":"智通财经APP讯，红日药业(300026.SZ)公告，公司近日收到国家药品监督管理局下发的药物临床试验批准通知书，公司申报的注射用多黏菌素E甲磺酸钠符合药品注册的有关要求，同意本品开展临床试验。申请的适应症为：本品适用于革兰氏阴性杆菌敏感菌株引起的急性或慢性感染。特别是由铜绿假单胞菌敏感菌株引起的感染。本品不适用于由变形杆菌或奈瑟菌引起的感染。本品对于由产气肠杆菌、大肠杆菌、肺炎克雷伯菌和铜绿假单胞菌引起的感染的临床有效性已经获得证实。本品可用于治疗疑似由革兰氏阴性菌引起的严重感染和敏感革兰氏阴性杆菌引起的感染。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620781361","isCrawlerRequest":true}